Immunoexpression of CTLA-4 in TCs was depicted in 237/264 (89.7%) of available tumor samples; it is further detailed in Table 5 and illustrative examples are depicted in Figure 2A,B and Supplementary Figure S5. The gene discussed is CTLA4; the disease is neoplasm.